Prothena | PRTA - Acreedores Comerciales

Precio De Mercado
10.75
Cambio Diario
0.02 0.19%
Mensual
15.47%
Anual
10.82%
Q2 Expectativa
10.43




Acreedores Comerciales Cambio Fecha
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
Agios Pharmaceuticals USD 18.36M 1.2M 2025-12
Akebia Therapeutics USD 21.18M 11.1M 2025-12
ALKERMES USD 107.95M 39.95M 2025-12
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Amgen USD 20.89B 1.25B 2025-12
Biogen USD 432M 18.9M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Exelixis USD 29.62M 4.27M 2025-12
Immunic USD 7.92M 25K 2025-09
Incyte USD 1.63B 1.46B 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
MacroGenics USD 4.79M 1.15M 2025-12
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Prothena USD 5.88M 4.63M 2025-12
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12
Xoma USD 2.65M 1.52M 2025-09